tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB

Genmab (GMAB) Similar Stocks

Compare
628 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$21.56
$13.97B
12.37
-16.43%
4 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$55.24
$10.79B
20.41
-34.36%
13 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$41.36
$11.39B
18.76
88.96%
10 Buy
6 Hold
0 Sell
Moderate Buy
Incyte
$68.27
$13.32B
211.23
11.12%
7 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$291.72
$13.02B
11.45
-4.68%
7 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$170.71
$10.44B
38.57%
14 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
21.56
-4.32
-16.69%
BMRN
BioMarin Pharmaceutical
55.24
-29.47
-34.79%
EXEL
Exelixis
40.74
19.01
87.48%
INCY
Incyte
68.27
5.91
9.48%
UTHR
United Therapeutics
291.72
-17.26
-5.59%
ASND
Ascendis Pharma
170.71
49.09
40.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis